Roche Signs Up to $1.1 Billion Drug Deal with Aileron

25.08.2010 - Swiss drugmaker Roche Holding is entering a deal with U.S.-based Aileron Therapeutics worth up to $1.1 billion, giving it access to a new way of targeting diseases. Aileron, which...